Abstract
Background
Post-ERCP pancreatitis (PEP) with trans-papillary approach remains a major issue, and the multi-factorial etiology can lead to the development of unpredictable PEP. Therefore, the early identification of PEP is highly desirable to assist with the health cost containment, the reduction in unnecessary admissions, earlier appropriate primary care, and intensive care for preventing progression of severe pancreatitis. This study aimed to establish a simplified predictive scoring system for PEP.
Methods
Between January 1, 2012, and December 31, 2019, 3362 consecutive trans-papillary ERCP procedures were retrospectively analyzed. Significant risk factors were extracted by univariate, multivariate, and propensity score analyses, and the probability of PEP in the combinations of each factor were quantified using propensity score analysis. The results were internally validated using bootstrapping resampling.
Results
In the scoring system with four stratifications using combinations of only five extracted risk factors, the very high-risk group showed 28.79% (95% confidence interval [CI], 18.30%–41.25%; P < 0.001) in the predicted incidence rate of PEP, and 9.09% (95% CI, 3.41%–18.74%; P < 0.001) in that of severe PEP; although the adjusted prevalence revealed 3.74% in PEP and 0.90% in severe PEP, respectively. The prediction model had an area under the curve of 0.86 (95% CI, 0.82–0.89) and the optimism-corrected model as an internal validation had an area under the curve of 0.81 (95% CI, 0.77–0.86).
Conclusions
We established and validated a simplified predictive scoring system for PEP using five risk factors immediately after ERCP to assist with the early identification of PEP.
Similar content being viewed by others
References
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS, Acute Pancreatitis Classification Working Group (2013) Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut 62:102–111
ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM (2017) Adverse events associated with ERCP. Gastrointest Endosc 85:32–47
Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, van Hooft JE (2020) ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 52:127–149
Leerhoy B, Elmunzer BJ (2018) How to avoid post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastrointest Endosc Clin N Am 28:439–454
Tryliskyy Y, Bryce GJ (2018) Post-ERCP pancreatitis: Pathophysiology, early identification and risk stratification. Adv Clin Exp Med 27:149–154
Neermark S, Rasmussen D, Rysgaard S, Gluud LL, Novovic S, Schmidt PN (2019) The cost of endoscopic treatment for walled-off pancreatic necrosis. Pancreatology 19:828–833
Nicolas-Perez D, Castilla-Rodriguez I, Gimeno-Garcia AZ, Romero-Garcia R, Nunez-Diaz V, Quintero E (2015) Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis. Pancreas 44:204–210
Zhang ZF, Duan ZJ, Wang LX, Zhao G, Deng WG (2017) Aggressive hydration with lactated Ringer solution in prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. J Clin Gastroenterol 51:e17–e26
Yu G, Li S, Wan R, Wang X, Hu G (2015) Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials. Pancreas 44:561–569
Kim SJ, Kang DH, Kim HW, Choi CW, Park SB, Song BJ, Nam HS (2016) A randomized comparative study of 24- and 6-hour infusion of nafamostat mesilate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective randomized comparison trial. Pancreas 45:1179–1183
Cote GA, Lynch S, Easler JJ, Keen A, Vassell PA, Sherman S, Hui S, Xu H (2015) Development and validation of a prediction model for admission after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 13:2323–32
Jeurnink SM, Siersema PD, Steyerberg EW, Dees J, Poley JW, Haringsma J, Kuipers EJ (2011) Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge. Surg Endosc 25:2892–2900
Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP (2001) Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54:425–434
Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis Or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg 102:148–158
Siau K, Dunckley P, Feeney M, Johnson G, Joint Advisory Group on Gastrointestinal Endoscopy (2019) ERCP assessment tool: evidence of validity and competency development during training. Endoscopy 51:1017–1026
Wani S, Han S, Simon V, Hall M, Early D, Aagaard E, Abidi WM, Banerjee S, Baron TH, Bartel M, Bowman E, Brauer BC, Buscaglia JM, Carlin L, Chak A, Chatrath H, Choudhary A, Confer B, Cote GA, Das KK, DiMaio CJ, Dries AM, Edmundowicz SA, El Chafic AH, El Hajj I, Ellert S, Ferreira J, Gamboa A, Gan IS, Gangarosa L, Gannavarapu B, Gordon SR, Guda NM, Hammad HT, Harris C, Jalaj S, Jowell P, Kenshil S, Klapman J, Kochman ML, Komanduri S, Lang G, Lee LS, Loren DE, Lukens FJ, Mullady D, Muthusamy RV, Nett AS, Olyaee MS, Pakseresht K, Perera P, Pfau P, Piraka C, Poneros JM, Rastogi A, Razzak A, Riff B, Saligram S, Scheiman JM, Schuster I, Shah RJ, Sharma R, Spaete JP, Singh A, Sohail M, Sreenarasimhaiah J, Stevens T, Tabibian JH, Tzimas D, Uppal DS, Urayama S, Vitterbo D, Wang AY, Wassef W, Yachimski P, Zepeda-Gomez S, Zuchelli T, Keswani RN (2019) Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees. Gastrointest Endosc 89:1160-1168.e9
Freeman ML, Guda NM (2005) ERCP cannulation: a review of reported techniques. Gastrointest Endosc 61:112–125
Tanaka R, Itoi T, Sofuni A, Itokawa F, Kurihara T, Tsuchiya T, Tsuji S, Ishii K, Ikeuchi N, Umeda J, Tonozuka R, Honjo M, Mukai S, Moriyasu F (2013) Is the double-guidewire technique superior to the pancreatic duct guidewire technique in cases of pancreatic duct opacification? J Gastroenterol Hepatol 28:1787–1793
Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, Itoi T, Sata N, Gabata T, Igarashi H, Kataoka K, Hirota M, Kadoya M, Kitamura N, Kimura Y, Kiriyama S, Shirai K, Hattori T, Takeda K, Takeyama Y, Hirota M, Sekimoto M, Shikata S, Arata S, Hirata K (2015) Japanese guidelines for the management of acute pancreatitis: Japanese guidelines 2015. J Hepatobiliary Pancreat Sci 22:405–432
Miura F, Okamoto K, Takada T, Strasberg SM, Asbun HJ, Pitt HA, Gomi H, Solomkin JS, Schlossberg D, Han HS, Kim MH, Hwang TL, Chen MF, Huang WS, Kiriyama S, Itoi T, Garden OJ, Liau KH, Horiguchi A, Liu KH, Su CH, Gouma DJ, Belli G, Dervenis C, Jagannath P, Chan ACW, Lau WY, Endo I, Suzuki K, Yoon YS, de Santibanes E, Gimenez ME, Jonas E, Singh H, Honda G, Asai K, Mori Y, Wada K, Higuchi R, Watanabe M, Rikiyama T, Sata N, Kano N, Umezawa A, Mukai S, Tokumura H, Hata J, Kozaka K, Iwashita Y, Hibi T, Yokoe M, Kimura T, Kitano S, Inomata M, Hirata K, Sumiyama Y, Inui K, Yamamoto M (2018) Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci 25:31–40
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N (1991) Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37:383–393
Mine T, Morizane T, Kawaguchi Y, Akashi R, Hanada K, Ito T, Kanno A, Kida M, Miyagawa H, Yamaguchi T, Mayumi T, Takeyama Y, Shimosegawa T (2017) Clinical practice guideline for post-ERCP pancreatitis. J Gastroenterol 52:1013–1022
Cepeda MS, Boston R, Farrar JT, Strom BL (2003) Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158:280–287
Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399–424
Efron B (1979) Bootstrap methods: another look at the Jackknife. Ann Statist 7:1–26
Steyerberg EW (2018) Validation in prediction research: the waste by data splitting. J Clin Epidemiol 103:131–133
Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774–781
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38:1569–1580
Ding X, Zhang F, Wang Y (2015) Risk factors for post-ERCP pancreatitis: a systematic review and meta-analysis. Surgeon 13:218–229
Sharaiha RZ, Khan MA, Kamal F, Tyberg A, Tombazzi CR, Ali B, Tombazzi C, Kahaleh M (2017) Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc 85:904–914
Ito K, Fujita N, Noda Y, Kobayashi G, Horaguchi J, Takasawa O, Obana T (2007) Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World J Gastroenterol 13:3855–3860
Jeurnink SM, Poley JW, Steyerberg EW, Kuipers EJ, Siersema PD (2008) ERCP as an outpatient treatment: a review. Gastrointest Endosc 68:118–123
Rabago L, Guerra I, Moran M, Quintanilla E, Collado D, Chico I, Olivares A, Castro JL, Gea F (2010) Is outpatient ERCP suitable, feasible, and safe? The experience of a Spanish community hospital. Surg Endosc 24:1701–1706
Acknowledgements
The authors thank the Department of Surgery, and the Division of Gastroenterology and Hepatology for patient recruitment. The authors also thank Enago for the English language editing of this paper.
Funding
The authors declare that no funding support was received for this study.
Author information
Authors and Affiliations
Contributions
Conception and design: MC and MK Performing endoscopic examinations: MC, MK, YK, NS, YT, TA, KK, ST, YT and HT Acquisition of data: MC, MK, YK, NS, YT and TA Statistical analysis: MC and MK Analysis and interpretation of the data: MC, MK, YK, NS, YT, TA, KK, ST, MN and YT Writing of the original paper: MC, MK and KS Revision of the paper: MC and MK Approval of the final draft submitted: All authors.
Corresponding author
Ethics declarations
Disclosures
Drs. Masafumi Chiba, Masayuki Kato, Yuji Kinoshita, Nana Shimamoto, Youichi Tomita, Takahiro Abe, Keisuke Kanazawa, Shintaro Tsukinaga, Masanori Nakano, Yuichi Torisu, Hirobumi Toyoizumi, and Kazuki Sumiyama have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chiba, M., Kato, M., Kinoshita, Y. et al. The milestone for preventing post-ERCP pancreatitis using novel simplified predictive scoring system: a propensity score analysis. Surg Endosc 35, 6696–6707 (2021). https://doi.org/10.1007/s00464-020-08173-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-08173-4